Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Bioretec

1.81

 

EUR

 

-4.74 %

1,557 following

BRETEC

First North Finland

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Investor consensus
Compare
-4.74%
-18.55%
-19.59%
-21.27%
-16.02%
-27.32%
-7.83%
-
-35.74%

Bioretec is a medical technology company. The company specializes in the development of medical devices. The product portfolio includes, for example, implants for pediatric and adult orthopedics and other material for bone and soft tissue injuries. In addition to the main business, service and associated ancillary services are also offered. Bioretec operates worldwide with the largest presence in the Nordic region.

Read more
Market cap
55.72M EUR
Turnover
33.55K EUR
P/E (adj.) (25e)
-11.29
EV/EBIT (adj.) (25e)
-10.83
P/B (25e)
4.13
EV/S (25e)
6.81
Dividend yield-% (25e)
-
Coverage
Recommendation
Accumulate
Target price
2.40 EUR
Updated
30.05.2025
Disclaimer
Antti Siltanen
Antti Siltanen

Analyst

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
14.8
2025

Interim report Q2'25

13.11
2025

Business review Q3'25

Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types
Regulatory press release5/28/2025, 11:00 AM

Inside information: Bioretec Ltd's Board of Directors resolved on a rights issue of approximately EUR 9.2 million and publishes the terms and conditions of the fully guaranteed rights issue

Bioretec
Regulatory press release5/20/2025, 11:00 AM

New shares of Bioretec Ltd subscribed with option rights have been registered with the trade register

Bioretec
Regulatory press release5/15/2025, 7:15 AM

Inside information: Sarah van Hellenberg Hubar-Fisher appointed interim CEO of Bioretec

Bioretec

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/15/2025, 5:00 AM

Bioretec Ltd's business review Q1 2025: Strong net sales in the first quarter; CE approval with comprehensive indications received in January accelerates the future expansion of RemeOs products

Bioretec
Regulatory press release5/8/2025, 3:45 PM

Inside information: Bioretec's CEO Alan Donze to resign

Bioretec
Regulatory press release4/9/2025, 2:15 PM

Bioretec Ltd - Managers' transactions - Alan Donze

Bioretec
Regulatory press release4/9/2025, 2:00 PM

Bioretec Ltd - Managers' transactions - Michael Piccirillo

Bioretec
Regulatory press release4/9/2025, 2:00 PM

Bioretec Ltd - Managers' transactions - Kustaa Poutiainen

Bioretec
Regulatory press release4/9/2025, 2:00 PM

Bioretec Ltd - Managers' transactions - Päivi Malinen

Bioretec
Regulatory press release4/9/2025, 2:00 PM

Bioretec Ltd - Managers' transactions - Sarah van Hellenberg Hubar-Fisher

Bioretec
Regulatory press release4/9/2025, 2:00 PM

Bioretec Ltd - Managers' transactions - Justin Barad

Bioretec
Regulatory press release4/9/2025, 2:00 PM

Bioretec Ltd - Managers' transactions - Antti Vasara

Bioretec
Regulatory press release3/21/2025, 1:00 PM

Bioretec Ltd's Board of Directors has decided on a new option program for the CEO

Bioretec
Regulatory press release3/21/2025, 12:30 PM

Resolutions of Bioretec Ltd's Annual General Meeting and the constitutive meeting of the Board of Directors

Bioretec
Regulatory press release3/14/2025, 5:30 PM

Bioretec Ltd: Notification in accordance with chapter 9, section 10 of the Securities Market Act on a change in holdings (W&M GmbH)

Bioretec
Press release3/14/2025, 5:00 PM

Bioretec Ltd's Annual Report 2024 published

Bioretec
Regulatory press release3/14/2025, 7:00 AM

New shares in Bioretec Ltd subscribed with option rights have been registered into the Trade Register

Bioretec
Press release3/7/2025, 7:00 AM

Mirva Ekman appointed to Bioretec's Management Team as Quality Director

Bioretec
Regulatory press release2/28/2025, 10:30 AM

Bioretec: NOTICE OF ANNUAL GENERAL MEETING OF BIORETEC LTD

Bioretec
Press release2/14/2025, 4:30 PM

CE Mark Approval for RemeOs™ Trauma Screw Product Group, featuring four product lines with over 200 individual products, drives global expansion for Bioretec

Bioretec
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team